BRPI0918722A2 - composição farmacêutica para tratar dor nociceptiva - Google Patents

composição farmacêutica para tratar dor nociceptiva

Info

Publication number
BRPI0918722A2
BRPI0918722A2 BRPI0918722A BRPI0918722A BRPI0918722A2 BR PI0918722 A2 BRPI0918722 A2 BR PI0918722A2 BR PI0918722 A BRPI0918722 A BR PI0918722A BR PI0918722 A BRPI0918722 A BR PI0918722A BR PI0918722 A2 BRPI0918722 A2 BR PI0918722A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
nociceptive pain
treat nociceptive
treat
pain
Prior art date
Application number
BRPI0918722A
Other languages
English (en)
Inventor
Akio Kuroda
Fusako Nishigaki
Kazumi Kikuchi
Nobuaki Takeshita
Seiji Tamura
Toshiaki Aoki
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of BRPI0918722A2 publication Critical patent/BRPI0918722A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BRPI0918722A 2008-09-11 2009-09-10 composição farmacêutica para tratar dor nociceptiva BRPI0918722A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008234069 2008-09-11
PCT/JP2009/065791 WO2010029958A1 (ja) 2008-09-11 2009-09-10 侵害受容性疼痛の新規治療用医薬組成物

Publications (1)

Publication Number Publication Date
BRPI0918722A2 true BRPI0918722A2 (pt) 2015-12-01

Family

ID=42005210

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0918722A BRPI0918722A2 (pt) 2008-09-11 2009-09-10 composição farmacêutica para tratar dor nociceptiva

Country Status (12)

Country Link
US (1) US20110152268A1 (pt)
EP (1) EP2329824A4 (pt)
JP (1) JPWO2010029958A1 (pt)
KR (1) KR20110071079A (pt)
CN (1) CN102149386A (pt)
AU (1) AU2009292498A1 (pt)
BR (1) BRPI0918722A2 (pt)
CA (1) CA2736559A1 (pt)
MX (1) MX2011002727A (pt)
RU (1) RU2011113722A (pt)
TW (1) TW201014833A (pt)
WO (1) WO2010029958A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3744323A4 (en) * 2018-01-26 2021-12-29 Ajinomoto Co., Inc. Composition for preventing or improving nociceptive pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4109088A (en) 1975-01-29 1978-08-22 Yamanouchi Pharmaceutical Co., Ltd. 2-(indenyloxymethyl) morpholine derivatives
AU2003296954A1 (en) * 2002-12-13 2004-07-09 The Regents Of The University Of California Analgesic combination comprising nalbuphine
WO2005051488A1 (en) * 2003-11-26 2005-06-09 Pfizer Products Inc. Combination of dopamine agonists and monoamine reuptake inhibitors
AR054045A1 (es) * 2005-05-18 2007-05-30 Neuraxon Inc Compuestos benzoimidazol sustituidos con actividad dual no inhibitoria y mu opioide agonista
ATE530175T1 (de) * 2006-06-08 2011-11-15 Ucb Pharma Gmbh Therapeutische kombination für schmerzhafte medizinische zustände
GB0701171D0 (en) 2007-01-22 2007-02-28 Imp Innovations Ltd Compositions and uses thereof
TW200846002A (en) 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy
TW200846003A (en) 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy
US20080287406A1 (en) * 2007-03-26 2008-11-20 Lessem Jan N Compositions and methods for treating medical conditions

Also Published As

Publication number Publication date
JPWO2010029958A1 (ja) 2012-02-02
EP2329824A4 (en) 2013-01-16
US20110152268A1 (en) 2011-06-23
EP2329824A1 (en) 2011-06-08
KR20110071079A (ko) 2011-06-28
MX2011002727A (es) 2011-04-21
CN102149386A (zh) 2011-08-10
WO2010029958A1 (ja) 2010-03-18
AU2009292498A1 (en) 2010-03-18
CA2736559A1 (en) 2010-03-18
RU2011113722A (ru) 2012-10-20
TW201014833A (en) 2010-04-16

Similar Documents

Publication Publication Date Title
BRPI0915476A2 (pt) dispositivo para tratar problemas respiratórios
BRPI1011587A2 (pt) compostos e composições terapèuticas
BRPI0908428A2 (pt) uso de ranozalina para tratar a dor.
BRPI0914614A2 (pt) 2-arilaminoquinazolinas para tratar doenças proliferativas
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
SMT201700095B (is) Composizioni farmaceutiche per inalazione
DK3097925T3 (da) Farmaceutisk sammensætning
BR112012004979A2 (pt) composições para o tratamento de semente e métodos
BRPI1004940A2 (pt) composição farmacêutica
BR112013014583A2 (pt) composição farmacêutica, e, métodos para o tratamento de inflamação, para o tratamento da dor, e para preparar 3-metanossulfonilpropionitrila
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
BR112012031836A2 (pt) combinação farmacêutica para o tratamento da dor
BRPI1015939A2 (pt) composição farmacêutica
DK3300729T3 (da) Terapeutiske sammensætninger indeholdende macitentan
BR112012004080A2 (pt) composições farmacêuticas para tratar ibd
BRPI1014528A2 (pt) compostos para tratamento de inflamação e dor
DK2285413T3 (da) Farmaceutisk sammensætning
EP2236149A4 (en) MEDICAL COMPOSITION
BRPI0921313A2 (pt) composição farmaucêutica
BRPI0722183A2 (pt) Composições farmacêuticas para tratar depressão e ansiedade
CO6801718A2 (es) Composición terapéutica para el tratamiento de glioblastoma
BR112012006437A2 (pt) composições e métodos para tratamento do diabetes e outros distúrbios
BRPI0822264A2 (pt) Dapsona para tratar rosácea
BRPI0921679A2 (pt) composto útil para tratar celulite
BRPI0917562A2 (pt) composições farmacêuticas e métodos para estabilizar as mesmas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2372 DE 21-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.